The Development of Topically Acting Carbonic Anhydrase Inhibitors as Antiglaucoma Agents

E-ISSN： 1873-4286|14|7|649-654

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.7, 2008-03, pp. : 649-654

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Development of Topically Acting Carbonic Anhydrase Inhibitors as Antiglaucoma Agents

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 9, 2007-05 ,pp. : 849-854

Bentham Science Publishers

Access to resources Recommend Favorite

Antiglaucoma carbonic anhydrase inhibitors: a patent review

By Masini Emanuela

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 6, 2013-06 ,pp. : 705-716

Informa Healthcare

Access to resources Recommend Favorite

Carbonic Anhydrase Inhibitors as Anticonvulsant Agents

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 9, 2007-05 ,pp. : 855-864

Bentham Science Publishers

Access to resources Recommend Favorite

Carbonic anhydrase inhibitors. Part 79 - Synthesis of topically acting sulfonamides incorporating GABA moieties in their molecule, with long-lasting intraocular pressure-lowering properties

By Mincione G. Menabuoni L. Briganti F. Mincione F. Scozzafava A. Supuran C.T.

European Journal of Pharmaceutical Sciences, Vol. 9, Iss. 2, 1999-12 ,pp. : 185-199

Elsevier

Access to resources Recommend Favorite

Quantitative Structure Activity Relationship Studies of Sulfamide Derivatives as Carbonic Anhydrase Inhibitor: As Antiglaucoma Agents

Medicinal Chemistry, Vol. 3, Iss. 4, 2007-01 ,pp. : 379-386

Bentham Science Publishers

Access to resources Recommend Favorite